Regenerative Medical Technology (RMTG) Convertible Debt (2019 - 2024)
Regenerative Medical Technology (RMTG) posted quarterly Convertible Debt of $40758.0 for Q3 2024, up 24.32% year-over-year from $32785.0 in Q4 2023, and up 8.68% quarter-over-quarter from $37502.0 in Q1 2024.
Regenerative Medical Technology (RMTG) Convertible Debt (2019 - 2024) Analysis & Trends
Regenerative Medical Technology's Convertible Debt history runs 6 years deep, the most recent figure standing at $40758.0 for Q3 2024.
- In Q3 2024, Convertible Debt rose 24.32% year-over-year to $40758.0; the TTM figure through Sep 2024 stood at $40758.0 (up 24.32% YoY), while the FY2023 annual figure was $35023.0, down 6.4% from the prior year.
- Convertible Debt for Q3 2024 stood at $40758.0, up from $37502.0 in the prior quarter.
- The five-year high for Convertible Debt was $220499.0 in Q2 2021, with the low at $2423.0 in Q1 2020.
- The 5-year median for Convertible Debt is $33383.5 (2021), against an average of $38148.6.
- The sharpest annual moves came in 2020 and 2022: Convertible Debt surged 26748.15% in 2020, then sank 83.94% in 2022.
- Regenerative Medical Technology's Convertible Debt stood at $14498.0 in 2020, then jumped by 134.39% to $33982.0 in 2021, then gained by 10.11% to $37419.0 in 2022, then retreated by 6.4% to $35023.0 in 2023, then gained by 16.37% to $40758.0 in 2024.
- Business Quant data shows RMTG's Convertible Debt at $40758.0 in Q3 2024, $37502.0 in Q1 2024, and $35023.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.50 Bn | 131.65 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.10 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.59 Bn | 60.41 Bn | 1.37 Bn |
| 4 | Moderna | 56.75 Bn | 51.62 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.64 Bn | 28.33 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.80 Bn | 9.41 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - |
| 10 | Regenerative Medical Technology | 919,727.76 | -141,720.24 | 1.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 40,758.00 |
| Mar 31, 2024 | 37,502.00 |
| Dec 31, 2023 | 35,023.00 |
| Sep 30, 2023 | 32,785.00 |
| Jun 30, 2023 | 30,547.00 |
| Mar 31, 2023 | 28,308.00 |
| Dec 31, 2022 | 37,419.00 |
| Sep 30, 2022 | 38,110.00 |
| Jun 30, 2022 | 35,402.00 |
| Mar 31, 2022 | 38,826.00 |
| Dec 31, 2021 | 33,982.00 |
| Sep 30, 2021 | 29,085.00 |
| Jun 30, 2021 | 220,499.00 |
| Mar 31, 2021 | 19,342.00 |
| Dec 31, 2020 | 14,498.00 |
| Sep 30, 2020 | 2,423.00 |
| Jun 30, 2020 | 9,742.00 |
| Mar 31, 2020 | 2,423.00 |
| Dec 31, 2019 | 54.00 |